A observational, retrospective, cohort study analysing efficacy, demographics and practice patterns immune checkpoint inhibitor (ICI) therapy in older adults with lung cancer
Latest Information Update: 18 Jun 2020
At a glance
- Drugs Atezolizumab (Primary) ; Nivolumab (Primary) ; Pembrolizumab (Primary)
- Indications Adenocarcinoma; Lung cancer; Squamous cell cancer
- Focus Therapeutic Use
Most Recent Events
- 18 Jun 2020 New trial record
- 31 May 2020 Results presented at the 56th Annual Meeting of the American Society of Clinical Oncology